- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03697447
Endermotherapy With Burn Hypertrophic Scars
August 20, 2024 updated by: Centre hospitalier de l'Université de Montréal (CHUM)
Randomized, Controlled, Within-patient, Singleblind Study to Evaluate the Efficacy of 12-weeks of Endermotherapy With Adult Burn Survivors
Mechanical massage or endermotherapyTM is applied to scar tissue with the intended therapeutic value being the promotion of structural or physiological changes.
These proposed changes are meant to induce more pliability, so that skin possesses the strength and elasticity required for normal mobility.
The advantage of mechanical massage compared to manual massage is that it provides a standard dosage using rollers and suction valves to mobilize the tissue.
However, research documenting and supporting this effect is lacking.
The objective of this proposal is to document the effect of 12 weeks of endermotherapy treatment on hypertrophic scar characteristics, including erythema, pigmentation, pliability, and thickness in adult burn survivors and their subjective evaluation of itch, pain and overall scar outcome through a prospective, randomized, controlled, within-patient, single-blinded study.
Study Overview
Detailed Description
Patients will receive 12 weeks of endermotherapy , 3 times a week.
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H2X 1C9
- Montreal Burn Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- females and males, of any race, 14 years or older,
- a thermal injury,
- at least 3 months post-burn so that the scars will be durable enough to tolerate the proposed forces,
- at least 2 scar sites >2.034 mm thick and within 0.5 mm of each other, and
- signed the informed patient consent form
Exclusion Criteria:
- subjects who have keloids,
- with a diagnosis of psychiatric illness clearly documented in their medical file,
- mechanism of injury is an electrical, chemical, or cold injury,
- a dermatological conditions in the region of the evaluation site, that may interfere with the study results,
- a suspected or known allergy to ultrasound gel,
- unable to understand French or English, or
- subjects who refuse to give informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control scar
No intervention, standard of care
|
|
|
Experimental: Endermotherapy treated scar
Endermotherapy massage treatment
|
Endermotherapy massage (mechanic massage) of burn scar
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin Thickness Changes
Time Frame: baseline, 12, 24 and 36 weeks
|
Ultrasound skin measures, mm
|
baseline, 12, 24 and 36 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cutometer Skin Elasticity Changes
Time Frame: baseline, 12, 24 and 36 weeks
|
skin elasticity measures (r0- cutometer), mm
|
baseline, 12, 24 and 36 weeks
|
|
Mexameter Skin Erythema Changes
Time Frame: baseline, 12, 24 and 36 weeks
|
Erythema index measure by Mexameter, scale values of 0 to 999.
The erythema values are individual for each person and depend strongly on the ethnic group.
The measurements are generally used to determine changes before and after a treatment.
|
baseline, 12, 24 and 36 weeks
|
|
Itch Visual Analog Subjective Changes
Time Frame: baseline, 12, 24 and 36 weeks
|
Itch, Visual analog scale (score 0-none to 10-worse)
|
baseline, 12, 24 and 36 weeks
|
|
Pain Visual Analog Subjective Changes: VAS
Time Frame: baseline, 12, 24 and 36 weeks
|
Pain, Visual analog scale (score 0-none to 10-worse)
|
baseline, 12, 24 and 36 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Bernadette Nedelec, PhD, CRCHUM
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 13, 2017
Primary Completion (Actual)
February 5, 2020
Study Completion (Actual)
February 5, 2020
Study Registration Dates
First Submitted
March 22, 2018
First Submitted That Met QC Criteria
October 4, 2018
First Posted (Actual)
October 5, 2018
Study Record Updates
Last Update Posted (Actual)
August 21, 2024
Last Update Submitted That Met QC Criteria
August 20, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15.374
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burn Scar
-
Riphah International UniversityRecruiting
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | ScarUnited States
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | Scar | Skin Graft ScarUnited States
-
Bispebjerg HospitalUnknownBurn Scar PatientsDenmark
-
University of PittsburghUnited States Department of DefenseTerminatedBurn Scar | Restrictive Scar Contracture | Restrictive Hypertrophic Scar | Burn Scar ContracturesUnited States
-
Centre hospitalier de l'Université de Montréal...Completed
-
Cairo UniversityCompletedBurns | Hypertrophic Scar | Burn Scar (Post-burn)Egypt
-
MTI UniversityCompleted
-
University Hospital, LinkoepingCompletedBurn Scar | Burns | Burn Second DegreeSweden
-
Kaiyang Lv, MD-PhDZimmer Medical Devices (Shanghai) Co., Ltd.RecruitingBurn Scar | Cryotherapy Effect | Scar; Previous Cesarean SectionChina
Clinical Trials on Endermotherapy
-
University of Sao PauloUnknownBurn | Skin GraftBrazil
-
The Hong Kong Polytechnic UniversityPhoelia Co. Ltd.CompletedCerebral Palsy | Developmental DelayHong Kong